OMERS Administration Corp’s Japer Therapeutics Warrants JSPRW Stock Holding History

OMERS Administration Corp’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21,300	Closed	-$25K	–	451
2021 Q2	$25K	Hold	21,300	–	–	﹤0.01%	417
2021 Q1	$17K	Sell	21,300 -21,200	-50%	-$31K	﹤0.01%	400
2020 Q4	$62K	Buy	+42,500	New	+$53.3K	﹤0.01%	258

Other funds holding JSPRW

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return

OMERS Administration Corp's JSPRW Position: Q3 2021 in Review

OMERS Administration Corp sold out of Japer Therapeutics Warrants (JSPRW) in Q3 2021, closing a stake of 21,300 shares — an estimated $25K sold.

OMERS Administration Corp first reported a position in JSPRW in Q4 2020 and held it in 3 quarters. The position peaked at $62K in Q4 2020. 16 funds tracked by Wall St. Rank hold JSPRW as of Q3 2021.

OMERS Administration Corp reported no remaining Japer Therapeutics Warrants position as of Q3 2021 after selling out during the quarter.
OMERS Administration Corp sold 21,300 Japer Therapeutics Warrants shares in Q3 2021, an estimated $25K.
OMERS Administration Corp first reported a position in Japer Therapeutics Warrants in Q4 2020 and held it in 3 quarters.
OMERS Administration Corp's Japer Therapeutics Warrants position peaked at $62K in Q4 2020.
16 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2021.

Based on OMERS Administration Corp's 13F filing for Q3 2021, filed 12 Nov 2021.